Showing results (51-60 of 139) with videos related to
Sort By:
Pageof 14
Cancer Research|July 29, 1998
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomasK T Wilson, S Fu, K S Ramanujam, et al.The American Journal of Gastroenterology|November 1, 1986
Appendiceal obstruction by a toothpick removed at colonoscopyS J Meltzer, M D Goldberg, R M Meltzer, et al.BJOG : an International Journal of Obstetrics and Gynaecology|January 29, 2010
Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methodsS J Meltzer, J Snyder, J R Penrod, et al.Gastroenterology|October 1, 1986
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel diseaseC J Haber, S J Meltzer, D H Present, et al.Cancer Genetics and Cytogenetics|October 15, 1993
Cytogenetic studies of primary cultures of esophageal squamous cell carcinomaL S Rosenblum-Vos, S J Meltzer, J Leana-Cox, et al.Leukemia|July 1, 1989
c-myc amplification coexistent with activating N-ras point mutation in the biphenotypic leukemic cell line RED-3M K Mallet, S M Mane, S J Meltzer, et al.Gastroenterology|July 1, 1994
Human papillomavirus DNA sequences in esophagus squamous cell carcinomaK Togawa, K Jaskiewicz, H Takahashi, et al.Biotechniques|August 1, 1991
Direct radioactive labeling of unpurified PCR products using Klenow fragmentT K McDaniel, Y Huang, J Yin, et al.Gastroenterology|May 1, 1987
Protooncogene abnormalities in colon cancers and adenomatous polypsS J Meltzer, D J Ahnen, H Battifora, et al.Annals of Internal Medicine|October 15, 1989
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicityD H Present, S J Meltzer, M P Krumholz, et al.Pageof 14